SEC Form 4 · accession 0000899243-15-001271
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frances K Heller
Director
Period of report
Jul 13, 2015
Accepted (ET)
Jul 15, 2015 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $37.15 | Jul 13, 2015 | A | 12,000 | A | — | Jul 13, 2025 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of the first anniversary of the date of the 2015 annual meeting of stockholders or the date of the 2016 annual meeting of stockholders.